Immunoglobulin replacement therapy in chronic lymphocytic leukaemia patients with hypogammaglobulinaemia and infection.

Anastazia KeeganPeta M DenningtonNina DhondyStephen P Mulligan

Published in: European journal of haematology (2022)

This study provides a globally unique insight into IgRT supply and demand in CLL patients by analysis of total national use in Australia over a 6-year period.

Keyphrases

replacement therapy
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
smoking cessation
prognostic factors
peritoneal dialysis
drug induced
chronic lymphocytic leukemia